Recurrence of tuberculosis in HIV-1-infected adults treated after rifamycin-based treatment and highly active antiretroviral therapy.
Hung
Chien-Ching
CC
Hsiao
Chin-Fu
CF
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis; D011446:Prospective Studies; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D012008:Recurrence; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012294:Rifamycins / Q000627:therapeutic use*; D013624:Taiwan; D014376:Tuberculosis / Q000150:complications* / Q000188:drug therapy / Q000821:virology
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D012367:RNA, Viral; D012294:Rifamycins